How Cardiac Surgeons Actually Use Risk Scores to Make Decisions — And What That Means for You

Your Risk Score Is Not Your Destiny

If you or someone you love has been told they need heart surgery, chances are a number has entered the conversation — a predicted risk of mortality or complications, often generated by something called the STS risk calculator. Maybe your surgeon mentioned it in passing. Maybe it appeared on a printed report. Maybe you Googled it at 2 a.m. and felt your stomach drop.

I want to be honest with you: that number matters. It is one of the most validated tools we have in cardiac surgery. But it is also, by itself, incomplete. As a practicing cardiovascular surgeon, I use risk scores on virtually every patient I evaluate. And every time, I interpret them within a much larger clinical picture that no algorithm can fully capture.

This article will walk you through how cardiac surgery risk assessment actually works in practice — what the numbers mean, where they fall short, and what questions you should be asking your surgical team before any final decision is made.

What the STS Risk Calculator Measures — And How It Works

The STS (Society of Thoracic Surgeons) risk calculator is the most widely used surgical risk prediction tool in North America. It was developed using outcomes data from millions of cardiac surgery cases and is updated regularly to reflect current practices and results.

When your surgeon enters your clinical information — age, sex, ejection fraction, kidney function, diabetes status, prior surgeries, and dozens of other variables — the calculator generates predicted risks for several outcomes:

• Operative mortality — the risk of dying during or within 30 days of surgery
• Major morbidity — the risk of serious complications like stroke, prolonged ventilation, kidney failure, deep wound infection, or reoperation
• Combined mortality and morbidity — perhaps the most clinically useful composite measure

The output is a percentage. For a coronary artery bypass (CABG) procedure, the national average predicted mortality is roughly 1-2%. For an aortic valve replacement, it might be 2-3%. These numbers shift significantly based on your individual profile.

So what does your STS score meaning actually translate to? In simple terms, it tells the surgical team — and you — what the statistical likelihood of certain adverse outcomes would be for someone with your particular combination of risk factors, based on the collective experience of thousands of surgeons and hundreds of thousands of patients.

You can explore a simplified version of this kind of assessment using our free cardiac surgery risk calculator, which provides an accessible starting point for understanding your risk profile.

Where Risk Scores Get It Right — And Where They Miss

I want to give credit where it is due. The STS risk models are remarkably well-calibrated across large populations. When the calculator predicts a 3% mortality rate for a group of patients with similar profiles, the actual observed mortality in that group tends to land very close to 3%. That kind of accuracy across hundreds of thousands of cases is genuinely impressive.

But here is the critical distinction that often gets lost in a brief office visit: population-level accuracy does not guarantee individual-level precision.

There are important factors that influence your personal surgical risk but are either poorly captured or entirely absent from the STS model:

• Frailty. A 78-year-old who walks two miles a day and a 78-year-old who cannot rise from a chair without assistance may generate the same STS score — but their real-world surgical risks are vastly different. Frailty assessments (grip strength, walking speed, nutritional status) are increasingly recognized as powerful predictors, yet they are not formal inputs in the standard STS calculator.
• Anatomical complexity. The STS score does not know that your coronary anatomy is unusually difficult to graft, or that your aorta is heavily calcified in a way that increases stroke risk during cannulation. These details live in your catheterization films and CT scans, not in a risk model's data fields.
• Surgeon and institutional volume. According to extensive literature — including data from the STS national database itself — outcomes for complex cardiac procedures are measurably better at high-volume centers with experienced surgical teams. Your STS score does not adjust for where or by whom your surgery will be performed.
• Patient goals and values. A predicted 5% mortality risk means something very different to a 55-year-old breadwinner with young children than it does to a 90-year-old who has clearly expressed a preference for comfort-focused care. The number is the same. The decision is not.

This is exactly why the ACC/AHA guidelines emphasize that risk scores should inform clinical decision-making, not replace it. The Heart Team model — where surgeons, interventional cardiologists, imaging specialists, and anesthesiologists collectively review your case — exists precisely because no single metric captures the full picture.

The EuroSCORE II and Other Tools

The STS calculator is not the only game in town. In Europe and many international centers, the EuroSCORE II is commonly used. It draws on a different patient dataset and uses a different statistical methodology. Other tools, like the ACEF score (which uses just age, ejection fraction, and creatinine) offer simpler but less granular estimates.

In my practice, I often calculate both STS predicted risk and EuroSCORE II for complex cases, especially when evaluating patients for transcatheter versus surgical approaches to valve disease. When the two models agree, that gives me greater confidence. When they diverge significantly, it tells me the case has nuances that deserve closer scrutiny — and often, a more detailed conversation with the patient.

How Risk Scores Influence Real Surgical Decisions

Let me give you a practical example of how cardiac surgery risk assessment shapes clinical decision-making.

Consider a 79-year-old woman with severe aortic stenosis. She has well-controlled diabetes, mild kidney impairment, and a prior history of coronary stenting. Her STS predicted risk of mortality for surgical aortic valve replacement (SAVR) comes back at 4.8%.

That number immediately places her in a category where both TAVR (transcatheter aortic valve replacement) and SAVR are reasonable options according to current guidelines. The 2020 ACC/AHA Valvular Heart Disease guidelines use STS score thresholds — along with frailty, anatomical considerations, and patient preference — to help guide the TAVR-versus-SAVR discussion:

• STS score less than 3% — SAVR is generally preferred in younger, lower-risk patients, given proven long-term durability
• STS score 3-8% — either TAVR or SAVR may be appropriate; shared decision-making is essential
• STS score greater than 8% — TAVR is generally favored, assuming suitable anatomy
• Prohibitive risk (or STS score suggesting very high mortality) — TAVR may be the only viable option, or in some cases, medical management alone may be most appropriate

But notice: even the guidelines themselves recognize that the score is a starting point. For our hypothetical patient at 4.8%, the decision depends on her valve anatomy (is it bicuspid? is there heavy calcium on the annulus?), her life expectancy independent of the valve disease, her functional status, and what matters most to her.

This is why a second set of expert eyes can be invaluable. If you have been quoted a risk score and given a recommendation but something feels uncertain, getting a second opinion is not a sign of distrust — it is sound medical judgment.

What You Should Ask Your Surgeon About Your Risk Score

Informed consent is not just a form you sign. It is a conversation. And you have every right to understand the numbers being used to guide your care. Here are specific questions I encourage patients and families to ask:

• "What is my STS predicted risk of mortality and morbidity?" — You deserve to know the actual numbers, not just a vague reassurance that you will be fine.
• "Are there risk factors in my case that the STS calculator does not fully account for?" — This opens the door for your surgeon to discuss frailty, anatomical challenges, or other nuances.
• "How does my risk compare to the national average for this procedure?" — Context matters. A 2% risk means something different if the national average is 1% versus 4%.
• "What is your personal and institutional experience with this operation?" — Volume and outcomes data matter. You are entitled to ask.
• "Would a less invasive approach change my risk profile meaningfully?" — For some patients, a minimally invasive or transcatheter option may offer a genuinely better risk-benefit ratio. For others, it may not. The answer is case-specific.
• "What happens if I do not have this surgery?" — Understanding the natural history of your condition without intervention is just as important as understanding the surgical risk. The risk of doing nothing is always part of the equation.

When a Second Opinion Changes the Calculation

In my experience reviewing cases for WhiteGloveMD second opinions, I frequently encounter situations where the initial risk assessment was technically accurate but the clinical recommendation could benefit from reconsideration. Some common scenarios:

• A patient classified as "high risk" on the STS calculator whose frailty was never formally assessed — and who, after proper evaluation, turns out to be a reasonable surgical candidate
• A patient steered toward a transcatheter approach when their anatomy actually favors open surgery with excellent expected long-term results
• A patient told their only option is medical management, when in fact a specialized center with higher-volume experience might offer an operative solution with acceptable risk
• A risk score that was calculated with incomplete or inaccurate input data — something I see more often than you would expect

Studies consistently show that second opinions in complex medical decision-making lead to a change in diagnosis or treatment plan in 10-60% of cases, depending on the clinical context. In cardiac surgery specifically, where the stakes are measured in years of life and quality of life, that range should give every patient pause.

A risk score is a tool. An important tool. But the interpretation of that tool — by a surgeon with deep experience, in the context of your complete medical story — is where the real value lies.

The Bottom Line

The STS risk calculator and similar scoring systems represent some of the best work our field has produced in measuring and communicating surgical risk. They ground our conversations in data rather than intuition alone. But they were never designed to make decisions for you or your surgeon. They were designed to make those decisions better-informed.

If you have been given a risk score and a surgical recommendation, take the time to understand both. Ask hard questions. And if anything about the recommendation feels unclear, incomplete, or just not right — trust that instinct.

If you are facing a cardiac surgery decision and want an independent, expert review of your risk assessment and treatment options, a WhiteGloveMD second opinion can help. Our team provides thorough, evidence-based evaluations led by a board-certified cardiovascular surgeon — so you can move forward with clarity and confidence.